Hier sehen Sie Publikationen zu manuell ausgewählten Personen. Der Filter ist sichtbar und wirkt nur in dieser Liste, Suchbegriffe können durch 'OR' oder 'AND' verknüpft werden, der Publikationsstatus wird angezeigt falls er von 'Publiziert' abweicht.

Liste von Publikationen:


Zeige Ergebnisse 21 - 40 von 76
Nowacka JD, Baumgartner C, Pelorosso C, Roth M, Zuber J, Baccarini M. MEK1 is required for the development of NRAS-driven leukemia. Onco Target. 2016;7(49):80113-80130. doi: 10.18632/oncotarget.12555

Liu ES, Raimann A, Chae BT, Martins JS, Baccarini M, Demay MB. c-Raf promotes angiogenesis during normal growth plate maturation. Development (Cambridge). 2016 Jan 15;143(2):348-355. doi: 10.1242/dev.127142

Jeric I, Maurer G, Cavallo AL, Raguz J, Desideri E, Tarkowski B et al. A cell-autonomous tumour suppressor role of RAF1 in hepatocarcinogenesis. Nature Communications. 2016 Dez 21;7:13781. doi: 10.1038/ncomms13781

Desideri E, Cavallo AL, Baccarini M. Alike but Different: RAF Paralogs and Their Signaling Outputs. Cell. 2015 Mai 21;161(5):967-970. doi: 10.1016/j.cell.2015.04.045

Baumgartner C, Baccarini M. p38 links RAS to GATA2. EMBO Reports. 2014 Sep;15(9):912-913. doi: 10.15252/embr.201439309

Cseh B, Doma E, Baccarini M. "RAF" neighborhood: Protein-protein interaction in the Raf/Mek/Erk pathway. FEBS Letters. 2014 Aug 1;588(15):2398-2406. doi: 10.1016/j.febslet.2014.06.025

Vin H, Ching G, Ojeda SS, Adelmann CH, Chitsazzadeh V, Dwyer DW et al. Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK. Molecular Cancer Therapeutics. 2014 Jan;13(1):221-229. doi: 10.1158/1535-7163.MCT-13-0561

Zmajkovicova K, Jesenberger V, Catalanotti F, Baumgartner C, Reyes G, Baccarini M. MEK1 Is Required for PTEN Membrane Recruitment, AKT Regulation, and the Maintenance of Peripheral Tolerance. Molecular Cell. 2013 Apr 11;50(1):43-55. doi: 10.1016/j.molcel.2013.01.037

Zeng L, Ehrenreiter K, Menon J, Menard R, Kern F, Nakazawa Y et al. RKIP regulates MAP kinase signaling in cells with defective B-Raf activity. Cellular signalling. 2013 Mai;25(5):1156-1165. doi: 10.1016/j.cellsig.2013.02.005

Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW et al. BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. eLife. 2013 Nov 5;2:00969. doi: 10.7554/eLife.00969

Eser S, Reiff N, Messer M, Seidler B, Gottschalk K, Dobler M et al. Selective Requirement of PI3K/PDK1 Signaling for Kras Oncogene-Driven Pancreatic Cell Plasticity and Cancer. Cancer Cell. 2013 Mär 18;23(3):406-420. doi: 10.1016/j.ccr.2013.01.023

Doma E, Rupp C, Varga A, Kern F, Riegler B, Baccarini M. Skin Tumorigenesis Stimulated by Raf Inhibitors Relies Upon Raf Functions That Are Dependent and Independent of ERK. Cancer Research. 2013 Dez 1;73(23):6926-6937. doi: 10.1158/0008-5472.CAN-13-0748

Maurer G, Tarkowski BM, Baccarini M. Raf kinases in cancer-roles and therapeutic opportunities. Oncogene: including Oncogene Reviews. 2011;30(32):3477-3488. doi: 10.1038/onc.2011.160

Schikora A, Virlogeux-Payant I, Bueso E, Garcia AV, Charrier A, Pelletier S et al. Conservation of Salmonella infection mechanisms in plants and animals. PLoS ONE. 2011;6(9). doi: 10.1371/journal.pone.0024112

Karreth FA, Frese KK, DeNicola GM, Baccarini M, Tuveson DA. C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D. Cancer Discovery. 2011;1(2):128-136. doi: 10.1158/2159-8290.CD-10-0044

Zeige Ergebnisse 21 - 40 von 76